These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 17766039

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Insulin-like growth factor-I controls BRCA1 gene expression through activation of transcription factor Sp1.
    Maor S, Papa MZ, Yarden RI, Friedman E, Lerenthal Y, Lee SW, Mayer D, Werner H.
    Horm Metab Res; 2007 Mar; 39(3):179-85. PubMed ID: 17373631
    [Abstract] [Full Text] [Related]

  • 3. Estrogen receptor regulates insulin-like growth factor-I receptor gene expression in breast tumor cells: involvement of transcription factor Sp1.
    Maor S, Mayer D, Yarden RI, Lee AV, Sarfstein R, Werner H, Papa MZ.
    J Endocrinol; 2006 Dec; 191(3):605-12. PubMed ID: 17170218
    [Abstract] [Full Text] [Related]

  • 4. Intratumoral IGF-I protein expression is selectively upregulated in breast cancer patients with BRCA1/2 mutations.
    Hudelist G, Wagner T, Rosner M, Fink-Retter A, Gschwantler-Kaulich D, Czerwenka K, Kroiss R, Tea M, Pischinger K, Köstler WJ, Attems J, Mueller R, Blaukopf C, Kubista E, Hengstschläger M, Singer CF.
    Endocr Relat Cancer; 2007 Dec; 14(4):1053-62. PubMed ID: 18045956
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Functional and physical interactions between BRCA1 and p53 in transcriptional regulation of the IGF-IR gene.
    Abramovitch S, Werner H.
    Horm Metab Res; 2003 Dec; 35(11-12):758-62. PubMed ID: 14710355
    [Abstract] [Full Text] [Related]

  • 7. Caveolin-1 up-regulates IGF-I receptor gene transcription in breast cancer cells via Sp1- and p53-dependent pathways.
    Glait C, Tencer L, Ravid D, Sarfstein R, Liscovitch M, Werner H.
    Exp Cell Res; 2006 Nov 15; 312(19):3899-908. PubMed ID: 17014845
    [Abstract] [Full Text] [Related]

  • 8. Repression of the insulin receptor promoter by the tumor suppressor gene product p53: a possible mechanism for receptor overexpression in breast cancer.
    Webster NJ, Resnik JL, Reichart DB, Strauss B, Haas M, Seely BL.
    Cancer Res; 1996 Jun 15; 56(12):2781-8. PubMed ID: 8665514
    [Abstract] [Full Text] [Related]

  • 9. Transcription factor E2F1 is a potent transactivator of the insulin-like growth factor-I receptor (IGF-IR) gene.
    Schayek H, Bentov I, Rotem I, Pasmanik-Chor M, Ginsberg D, Plymate SR, Werner H.
    Growth Horm IGF Res; 2010 Feb 15; 20(1):68-72. PubMed ID: 19703789
    [Abstract] [Full Text] [Related]

  • 10. Transcriptional regulation of the insulin-like growth factor-I receptor gene in breast cancer.
    Sarfstein R, Maor S, Reizner N, Abramovitch S, Werner H.
    Mol Cell Endocrinol; 2006 Jun 27; 252(1-2):241-6. PubMed ID: 16647191
    [Abstract] [Full Text] [Related]

  • 11. The WT1 Wilms' tumor suppressor gene product interacts with estrogen receptor-alpha and regulates IGF-I receptor gene transcription in breast cancer cells.
    Reizner N, Maor S, Sarfstein R, Abramovitch S, Welshons WV, Curran EM, Lee AV, Werner H.
    J Mol Endocrinol; 2005 Aug 27; 35(1):135-44. PubMed ID: 16087727
    [Abstract] [Full Text] [Related]

  • 12. The insulin-like growth factor-I receptor gene: a downstream target for oncogene and tumor suppressor action.
    Werner H, Maor S.
    Trends Endocrinol Metab; 2006 Aug 27; 17(6):236-42. PubMed ID: 16815029
    [Abstract] [Full Text] [Related]

  • 13. Insulin-like growth factor-I receptor overexpression mediates cellular radioresistance and local breast cancer recurrence after lumpectomy and radiation.
    Turner BC, Haffty BG, Narayanan L, Yuan J, Havre PA, Gumbs AA, Kaplan L, Burgaud JL, Carter D, Baserga R, Glazer PM.
    Cancer Res; 1997 Aug 01; 57(15):3079-83. PubMed ID: 9242428
    [Abstract] [Full Text] [Related]

  • 14. Phosphorylated insulin-like growth factor-i/insulin receptor is present in all breast cancer subtypes and is related to poor survival.
    Law JH, Habibi G, Hu K, Masoudi H, Wang MY, Stratford AL, Park E, Gee JM, Finlay P, Jones HE, Nicholson RI, Carboni J, Gottardis M, Pollak M, Dunn SE.
    Cancer Res; 2008 Dec 15; 68(24):10238-46. PubMed ID: 19074892
    [Abstract] [Full Text] [Related]

  • 15. [shRNA-mediated insulin-like growth factor I receptor gene silencing inhibits cell proliferation, induces cell apoptosis, and suppresses tumor growth in non-small cell lung cancer: in vitro and in vivo experiments].
    Dong AQ, Kong MJ, Ma ZY, Qian JF, Fan JQ, Xu XH.
    Zhonghua Yi Xue Za Zhi; 2007 Jun 05; 87(21):1506-9. PubMed ID: 17785094
    [Abstract] [Full Text] [Related]

  • 16. HMGA1 protein is a positive regulator of the insulin-like growth factor-I receptor gene.
    Aiello A, Pandini G, Sarfstein R, Werner H, Manfioletti G, Vigneri R, Belfiore A.
    Eur J Cancer; 2010 Jul 05; 46(10):1919-26. PubMed ID: 20335021
    [Abstract] [Full Text] [Related]

  • 17. BRCA1-Sp1 interactions in transcriptional regulation of the IGF-IR gene.
    Abramovitch S, Glaser T, Ouchi T, Werner H.
    FEBS Lett; 2003 Apr 24; 541(1-3):149-54. PubMed ID: 12706836
    [Abstract] [Full Text] [Related]

  • 18. Expression of the insulin-like growth factor-I receptor in primary breast cancer and lymph node metastases: correlations with estrogen receptors alpha and beta.
    Koda M, Sulkowski S, Garofalo C, Kanczuga-Koda L, Sulkowska M, Surmacz E.
    Horm Metab Res; 2003 Apr 24; 35(11-12):794-801. PubMed ID: 14710360
    [Abstract] [Full Text] [Related]

  • 19. Familial breast cancers without mutations in BRCA1 or BRCA2 have low cyclin E and high cyclin D1 in contrast to cancers in BRCA mutation carriers.
    Aaltonen K, Blomqvist C, Amini RM, Eerola H, Aittomäki K, Heikkilä P, Nevanlinna H.
    Clin Cancer Res; 2008 Apr 01; 14(7):1976-83. PubMed ID: 18381935
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.